banner add

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

from NYT > Health https://ift.tt/1ViXPCn
via IFTTT

No comments

Employer Health Costs Are Expected to Spike in 2027

A new U.S. survey anticipates an average increase of 11 percent unless benefits are cut, the highest rate in decades. Other findings also pr...

Theme images by PLAINVIEW. Powered by Blogger.